These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 35333325)

  • 1. Elevated numbers of infiltrating eosinophils accelerate the progression of Duchenne muscular dystrophy pathology in mdx mice.
    Theret M; Rempel L; Hashimoto J; Ritso M; Tung LW; Li FF; Messing M; Hughes M; McNagny K; Rossi F
    Development; 2022 Apr; 149(8):. PubMed ID: 35333325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eosinophils Do Not Drive Acute Muscle Pathology in the mdx Mouse Model of Duchenne Muscular Dystrophy.
    Sek AC; Moore IN; Smelkinson MG; Pak K; Minai M; Smith R; Ma M; Percopo CM; Rosenberg HF
    J Immunol; 2019 Jul; 203(2):476-484. PubMed ID: 31142604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Major basic protein-1 promotes fibrosis of dystrophic muscle and attenuates the cellular immune response in muscular dystrophy.
    Wehling-Henricks M; Sokolow S; Lee JJ; Myung KH; Villalta SA; Tidball JG
    Hum Mol Genet; 2008 Aug; 17(15):2280-92. PubMed ID: 18430716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A stromal progenitor and ILC2 niche promotes muscle eosinophilia and fibrosis-associated gene expression.
    Kastenschmidt JM; Coulis G; Farahat PK; Pham P; Rios R; Cristal TT; Mannaa AH; Ayer RE; Yahia R; Deshpande AA; Hughes BS; Savage AK; Giesige CR; Harper SQ; Locksley RM; Mozaffar T; Villalta SA
    Cell Rep; 2021 Apr; 35(2):108997. PubMed ID: 33852849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
    Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS
    Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological Inhibition of PKCθ Counteracts Muscle Disease in a Mouse Model of Duchenne Muscular Dystrophy.
    Marrocco V; Fiore P; Benedetti A; Pisu S; Rizzuto E; Musarò A; Madaro L; Lozanoska-Ochser B; Bouché M
    EBioMedicine; 2017 Feb; 16():150-161. PubMed ID: 28089792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delayed bone regeneration is linked to chronic inflammation in murine muscular dystrophy.
    Abou-Khalil R; Yang F; Mortreux M; Lieu S; Yu YY; Wurmser M; Pereira C; Relaix F; Miclau T; Marcucio RS; Colnot C
    J Bone Miner Res; 2014 Feb; 29(2):304-15. PubMed ID: 23857747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-10 reduces the pathology of mdx muscular dystrophy by deactivating M1 macrophages and modulating macrophage phenotype.
    Villalta SA; Rinaldi C; Deng B; Liu G; Fedor B; Tidball JG
    Hum Mol Genet; 2011 Feb; 20(4):790-805. PubMed ID: 21118895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-146a deficiency does not aggravate muscular dystrophy in mdx mice.
    Bronisz-Budzyńska I; Chwalenia K; Mucha O; Podkalicka P; Karolina-Bukowska-Strakova ; Józkowicz A; Łoboda A; Kozakowska M; Dulak J
    Skelet Muscle; 2019 Aug; 9(1):22. PubMed ID: 31412923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IFN-γ promotes muscle damage in the mdx mouse model of Duchenne muscular dystrophy by suppressing M2 macrophage activation and inhibiting muscle cell proliferation.
    Villalta SA; Deng B; Rinaldi C; Wehling-Henricks M; Tidball JG
    J Immunol; 2011 Nov; 187(10):5419-28. PubMed ID: 22013114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The D2.mdx mouse as a preclinical model of the skeletal muscle pathology associated with Duchenne muscular dystrophy.
    Hammers DW; Hart CC; Matheny MK; Wright LA; Armellini M; Barton ER; Sweeney HL
    Sci Rep; 2020 Aug; 10(1):14070. PubMed ID: 32826942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Murine models of Duchenne muscular dystrophy: is there a best model?
    Swiderski K; Lynch GS
    Am J Physiol Cell Physiol; 2021 Aug; 321(2):C409-C412. PubMed ID: 34260298
    [No Abstract]   [Full Text] [Related]  

  • 13. Magnetic resonance quantification of skeletal muscle lipid infiltration in a humanized mouse model of Duchenne muscular dystrophy.
    Khattri RB; Batra A; Matheny M; Hart C; Henley-Beasley SC; Hammers D; Zeng H; White Z; Ryan TE; Barton E; Bernatchez P; Walter GA
    NMR Biomed; 2023 Mar; 36(3):e4869. PubMed ID: 36331178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro assessment of anti-fibrotic drug activity does not predict in vivo efficacy in murine models of Duchenne muscular dystrophy.
    Theret M; Low M; Rempel L; Li FF; Tung LW; Contreras O; Chang CK; Wu A; Soliman H; Rossi FMV
    Life Sci; 2021 Aug; 279():119482. PubMed ID: 33891939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deletion of Galgt2 (B4Galnt2) reduces muscle growth in response to acute injury and increases muscle inflammation and pathology in dystrophin-deficient mice.
    Xu R; Singhal N; Serinagaoglu Y; Chandrasekharan K; Joshi M; Bauer JA; Janssen PM; Martin PT
    Am J Pathol; 2015 Oct; 185(10):2668-84. PubMed ID: 26435413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased plasma lipid levels exacerbate muscle pathology in the mdx mouse model of Duchenne muscular dystrophy.
    Milad N; White Z; Tehrani AY; Sellers S; Rossi FMV; Bernatchez P
    Skelet Muscle; 2017 Sep; 7(1):19. PubMed ID: 28899419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammasome Activity in the Skeletal Muscle and Heart of Rodent Models for Duchenne Muscular Dystrophy.
    Onódi Z; Szabó PL; Kucsera D; Pokreisz P; Dostal C; Hilber K; Oudit GY; Podesser BK; Ferdinandy P; Varga ZV; Kiss A
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37239853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Shifts in macrophage phenotypes and macrophage competition for arginine metabolism affect the severity of muscle pathology in muscular dystrophy.
    Villalta SA; Nguyen HX; Deng B; Gotoh T; Tidball JG
    Hum Mol Genet; 2009 Feb; 18(3):482-96. PubMed ID: 18996917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Whole-body clearing, staining and screening of calcium deposits in the mdx mouse model of Duchenne muscular dystrophy.
    Bozycki L; Łukasiewicz K; Matryba P; Pikula S
    Skelet Muscle; 2018 Jul; 8(1):21. PubMed ID: 30025544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contractile efficiency of dystrophic mdx mouse muscle: in vivo and ex vivo assessment of adaptation to exercise of functional end points.
    Capogrosso RF; Mantuano P; Cozzoli A; Sanarica F; Massari AM; Conte E; Fonzino A; Giustino A; Rolland JF; Quaranta A; De Bellis M; Camerino GM; Grange RW; De Luca A
    J Appl Physiol (1985); 2017 Apr; 122(4):828-843. PubMed ID: 28057817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.